I agree that this site is using cookies. You can find further informations here.
X
Kow, Chia Siang
362  results:
Search for persons X
?
1

Unlocking the enigma: Metabolic risks of typical antipsycho..:

Kow, Chia Siang ; Ramachandram, Dinesh Sangarran ; Hasan, Syed Shahzad
European Neuropsychopharmacology.  78 (2024)  - p. 1-2 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Pharmacological interventions to improve sleep in people wi..:

Bedward, Amy ; Kaur, Jasmine ; Seedat, Sadiyah...
Expert Review of Neurotherapeutics.  24 (2024)  5 - p. 527-539 , 2024
Link: https://doi.org/10.1080/..
 
?
3

Unveiling the nexus: Understanding post-COVID parkinsonism ..:

Kow, Chia Siang ; Ramachandram, Dinesh Sangarran ; Hasan, Syed Shahzad.
Parkinsonism & Related Disorders.  124 (2024)  - p. 106974 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Letter to the editor: Critical need for robust surveillance..:

Kow, Chia Siang ; Ramachandram, Dinesh Sangarran ; Hasan, Syed Shahzad.
Eurosurveillance.  29 (2024)  19 - p. , 2024
Link: https://doi.org/10.2807/..
 
?
5

Comment on: "Polypharmacy and Antibody Response to SARS-CoV..:

Kow, Chia Siang ; Ramachandram, Dinesh Sangarran ; Hasan, Syed Shahzad.
Drugs & Aging.  41 (2024)  3 - p. 283-285 , 2024
Link: https://doi.org/10.1007/..
 
?
6

Insights into COVID‐19 pneumonia among older adults: Unders..:

Kow, Chia Siang ; Ramachandram, Dinesh Sangarran ; Hasan, Syed Shahzad.
Journal of the American Geriatrics Society.  , 2024
Link: https://doi.org/10.1111/..
 
?
7

Antibiotics in COVID‐19: Unveiling disturbing truths throug..:

Kow, Chia Siang ; Ramachandram, Dinesh Sangarran ; Hasan, Syed Shahzad.
Journal of Medical Virology.  96 (2024)  6 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
8

Navigating the Shadows: COVID-19′s Lingering Threat – Pulmo..:

Kow, Chia Siang ; Ramachandram, Dinesh Sangarran ; Hasan, Syed Shahzad.
The American Journal of Medicine.  137 (2024)  4 - p. e81 , 2024
Link: https://doi.org/10.1016/..
 
?
9

Effect of intravenous immunoglobulin on mortality in hospit..:

Ramachandram, Dinesh Sangarran ; Kow, Chia Siang ; Hasan, Syed Shahzad.
Health Science Reports.  7 (2024)  7 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
10

Impact of uricosurics on mortality outcomes in patients wit..:

Kow, Chia Siang ; Ramachandram, Dinesh Sangarran ; Hasan, Syed Shahzad.
International Journal of Pharmacy Practice.  32 (2024)  3 - p. 259-264 , 2024
Link: https://doi.org/10.1093/..
 
?
11

Comment on: "Comparison of Clinical Outcomes Between Ticagr..:

Kow, Chia Siang ; Zaihan, Abdullah Faiz ; Ramachandram, Dinesh Sangarran.
American Journal of Cardiovascular Drugs.  24 (2024)  2 - p. 325-326 , 2024
Link: https://doi.org/10.1007/..
 
?
12

Therapeutic-dose heparin in preventing COVID-19–associated ..:

Kow, Chia Siang ; Thiruchelvam, Kaeshaelya
Research and Practice in Thrombosis and Haemostasis.  7 (2023)  8 - p. 102246 , 2023
Link: https://doi.org/10.1016/..
 
?
13

RAAS inhibitors in COVID-19: They are not all the same!:

Kow, Chia Siang ; Ramachandram, Dinesh Sangarran ; Hasan, Syed Shahzad
Revista Portuguesa de Cardiologia.  42 (2023)  9 - p. 815-816 , 2023
Link: https://doi.org/10.1016/..
 
?
14

Favipiravir and hyperuricemia in patients with COVID-19—sug..:

Kow, Chia Siang ; Ramachandram, Dinesh Sangarran ; Hasan, Syed Shahzad
The Lancet Regional Health - Southeast Asia.  16 (2023)  - p. 100267 , 2023
Link: https://doi.org/10.1016/..
 
?
15

Systematic review and meta-analysis of anti-CD20 treatments..:

Kow, Chia Siang ; Ramachandram, Dinesh Sangarran ; Hasan, Syed Shahzad.
Inflammopharmacology.  31 (2023)  6 - p. 3339-3355 , 2023
Link: https://doi.org/10.1007/..
 
1-15